Essjay & Sagittal 2026 Offsite: Regulatory Updates
Sagittal Pharma Consulting
Essjay & Sagittal 2026 Offsite: Regulatory Updates
44:33
Essjay & Sagittal 2026 Offsite: AI Update
Sagittal Pharma Consulting
Essjay & Sagittal 2026 Offsite: AI Update
44:19
Essjay & Sagittal 2026 Offsite: ICH GCP E6 (R3): Risk Expectations vs Reality
Sagittal Pharma Consulting
Essjay & Sagittal 2026 Offsite: ICH GCP E6 (R3): Risk Expectations vs Reality
53:42
Essjay & Sagittal 2026 Offsite: CIOMS Benefit Risk Framework
Sagittal Pharma Consulting
Essjay & Sagittal 2026 Offsite: CIOMS Benefit Risk Framework
55:50
R3 Taster Webinar
Sagittal Pharma Consulting
R3 Taster Webinar
17:29
AI/ChatGPT: Everything you wanted to know but were afraid to ask!
Sagittal Pharma Consulting
AI/ChatGPT: Everything you wanted to know but were afraid to ask!
27:37
How to Manage Global LSO/Local QPPV Requirements
Sagittal Pharma Consulting
How to Manage Global LSO/Local QPPV Requirements
28:57
Globalisation of QP Requirements
Sagittal Pharma Consulting
Globalisation of QP Requirements
32:09
QPPV and local requirements
Sagittal Pharma Consulting
QPPV and local requirements
32:09
Unlock the Secrets of the EU Marketing Authorization Application
Sagittal Pharma Consulting
Unlock the Secrets of the EU Marketing Authorization Application
29:48
Risk Minimisation
Sagittal Pharma Consulting
Risk Minimisation
28:20
Tip tips for report writing in pharmacovigilance
Sagittal Pharma Consulting
Tip tips for report writing in pharmacovigilance
36:24
Signal Detection in PV
Sagittal Pharma Consulting
Signal Detection in PV
32:41
Literature Monitoring and Review
Sagittal Pharma Consulting
Literature Monitoring and Review
36:47
Post Authorisation Safety
Sagittal Pharma Consulting
Post Authorisation Safety
36:17
Medication Errors
Sagittal Pharma Consulting
Medication Errors
33:50
Device Vigilance in PV
Sagittal Pharma Consulting
Device Vigilance in PV
37:02
GVP Modules
Sagittal Pharma Consulting
GVP Modules
36:39
The Importance of the Quality Management System
Sagittal Pharma Consulting
The Importance of the Quality Management System
36:57
Types of pharmacoepidemiological studies and what their biases may be
Sagittal Pharma Consulting
Types of pharmacoepidemiological studies and what their biases may be
33:53
Causality Assessments
Sagittal Pharma Consulting
Causality Assessments
32:21
Compliant & Effective Market Research Results
Sagittal Pharma Consulting
Compliant & Effective Market Research Results
22:10
Understanding the GVP Module V
Sagittal Pharma Consulting
Understanding the GVP Module V
40:24
Advisory Board Meeting
Sagittal Pharma Consulting
Advisory Board Meeting
18:15
Signal Detection and Eudravigilance
Sagittal Pharma Consulting
Signal Detection and Eudravigilance
43:41
Case Processing and Eudravigilance
Sagittal Pharma Consulting
Case Processing and Eudravigilance
43:58
Reference Safety Information
Sagittal Pharma Consulting
Reference Safety Information
33:25